Related references
Note: Only part of the references are listed.TERT promoter mutations: a genetic signature of benign and malignant thyroid tumours occurring in the context of tinea capitis irradiation
Paula Boaventura et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Comprehensive screening for PD-L1 expression in thyroid cancer
Soomin Ahn et al.
ENDOCRINE-RELATED CANCER (2017)
TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease
Miguel Melo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study
Nicholas E. Khan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study
Ashish V. Chintakuntlawar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Exceptional Response with Immunotherapy in a Patient with Anaplastic Thyroid Cancer
Revathi Kollipara et al.
ONCOLOGIST (2017)
THADA fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer
Federica Panebianco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Preoperative detection of RAS mutation may guide extent of thyroidectomy
Snehal G. Patel et al.
SURGERY (2017)
Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer
Zakaria Y. Abd Elmageed et al.
SURGERY (2017)
Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis
Shinje Moon et al.
THYROID (2017)
Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET, in Thyroid Cancers of Young Patients in Fukushima
Keita Iyama et al.
THYROID (2017)
Detecting Gene Rearrangements in Patient Populations Through a 2-Step Diagnostic Test Comprised of Rapid IHC Enrichment Followed by Sensitive Next-Generation Sequencing
Danielle A. Murphy et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2017)
Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer
Eric J. Sherman et al.
CANCER (2017)
Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence
Tihana Ibrahimpasic et al.
CLINICAL CANCER RESEARCH (2017)
Benign thyroid nodules with RAS mutation grow faster
Alessandro Puzziello et al.
CLINICAL ENDOCRINOLOGY (2016)
MicroRNA in diagnostics and therapy of thyroid cancer
Anna Wojcicka et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States
Manju L. Prasad et al.
CANCER (2016)
Prevalence and phenotypic correlations of EIF1AX mutations in thyroid nodules
Arivarasan Karunamurthy et al.
ENDOCRINE-RELATED CANCER (2016)
Familial non-medullary thyroid cancer: unraveling the genetic maze
Samantha Peiling Yang et al.
ENDOCRINE-RELATED CANCER (2016)
Immunohistochemical detection of NRASQ61R protein in follicular-patterned thyroid tumors
Naoki Oishi et al.
HUMAN PATHOLOGY (2016)
Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants
Xiaoguang Shi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Papillary Thyroid Carcinoma With Rare Exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience
Liborio Torregrossa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomas
Davide Calebiro et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Inigo Lancia et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Response to Targeted Therapy in BRAF Mutant Anaplastic Thyroid Cancer
Rishi Agarwal et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
Vemurafenib in patients with BRAFV600E-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial
Marcia S. Brose et al.
LANCET ONCOLOGY (2016)
Biologic and Clinical Perspectives on Thyroid Cancer
James A. Fagin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAFK601E Mutation
Michelle Afkhami et al.
THYROID (2016)
An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer
Iain J. Nixon et al.
THYROID (2016)
Associations between BRAFV600E and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis
Chunping Liu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2016)
Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer
Eran Brauner et al.
ONCOTARGET (2016)
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma A Paradigm Shift to Reduce Overtreatment of Indolent Tumors
Yuri E. Nikiforov et al.
JAMA ONCOLOGY (2016)
A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid Carcinoma
Angela Chou et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors
Cecilia Evangelisti et al.
BMC CANCER (2015)
The RET oncogene in papillary thyroid carcinoma
Jason D. Prescott et al.
CANCER (2015)
PTEN and TP53 Mutations in Oncocytic Follicular Carcinoma
Shuanzeng Wei et al.
ENDOCRINE PATHOLOGY (2015)
Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing
John W. Kunstman et al.
HUMAN MOLECULAR GENETICS (2015)
Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer
Mingzhao Xing et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase-Rearranged Anaplastic Thyroid Carcinoma
Yann Godbert et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study
Giovanni Tallini et al.
MODERN PATHOLOGY (2015)
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
Martin Schlumberger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
MicroRNA Expression and Association with Clinicopathologic Features in Papillary Thyroid Cancer: A Systematic Review
Patricia Aragon Han et al.
THYROID (2015)
BRAF Inhibitor Dabrafenib in Patients with Metastatic BRAF-Mutant Thyroid Cancer
Gerald S. Falchook et al.
THYROID (2015)
ETV6-NTRK3 Is a Common Chromosomal Rearrangement in Radiation-Associated Thyroid Cancer
Rebecca J. Leeman-Neill et al.
CANCER (2014)
TERT Promoter Mutation as an Early Genetic Event Activating Telomerase in Follicular Thyroid Adenoma (FTA) and Atypical FTA
Na Wang et al.
CANCER (2014)
Highly Accurate Diagnosis of Cancer in Thyroid Nodules With Follicular Neoplasm/Suspicious for a Follicular Neoplasm Cytology by ThyroSeq v2 Next-Generation Sequencing Assay
Yuri E. Nikiforov et al.
CANCER (2014)
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Nishant Agrawal et al.
CELL (2014)
Molecular Pathways: Adaptive Kinome Reprogramming in Response to Targeted Inhibition of the BRAF-MEK-ERK Pathway in Cancer
Gary L. Johnson et al.
CLINICAL CANCER RESEARCH (2014)
Correlations between the Expression Levels of Micro-RNA146b, 221, 222 and p27Kip1 protein mRNA and the Clinicopathologic Parameters in Papillary Thyroid Cancers
F. Acibucu et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2014)
miRNAs with the Potential to Distinguish Follicular Thyroid Carcinomas from Benign Follicular Thyroid Tumors: Results of a Meta- analysis
T. Stokowy et al.
HORMONE AND METABOLIC RESEARCH (2014)
High-Sensitivity BRAF Mutation Analysis: BRAF V600E Is Acquired Early During Tumor Development but Is Heterogeneously Distributed in a Subset of Papillary Thyroid Carcinomas
Dario de Biase et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Identification of Oncogenic Mutations and Gene Fusions in the Follicular Variant of Papillary Thyroid Carcinoma
David G. McFadden et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
The Increase in Thyroid Cancer Incidence During the Last Four Decades Is Accompanied by a High Frequency of BRAF Mutations and a Sharp Increase in RAS Mutations
Chan Kwon Jung et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Cell Cycle Deregulation and TP53 and RAS Mutations Are Major Events in Poorly Differentiated and Undifferentiated Thyroid Carcinomas
Jaime Miguel Pita et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
TERT Promoter Mutations and Their Association with BRAF V600E Mutation and Aggressive Clinicopathological Characteristics of Thyroid Cancer
Xiaoli Liu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas
Miguel Melo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Outcomes in Patients With Poorly Differentiated Thyroid Carcinoma
T. Ibrahimpasic et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence
Mingzhao Xing et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights
Matthias S. Dettmer et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2014)
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
Marcia S. Brose et al.
LANCET (2014)
Response and Acquired Resistance to Everolimus in Anaplastic Thyroid Cancer
Nikhil Wagle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas
T. Liu et al.
ONCOGENE (2014)
Identification of a Recurrent STRN/ALK Fusion in Thyroid Carcinomas
Gaelle Perot et al.
PLOS ONE (2014)
miRNA Expression in Anaplastic Thyroid Carcinomas
Aline Hebrant et al.
PLOS ONE (2014)
Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer
Lindsey M. Kelly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer
Piril Erler et al.
SURGERY (2014)
NRAS Codon 61 Mutation Is Associated with Distant Metastasis in Patients with Follicular Thyroid Carcinoma
Eun Kyung Jang et al.
THYROID (2014)
BRAFV600E in Papillary Thyroid Carcinoma Is Associated with Increased Programmed Death Ligand 1 Expression and Suppressive Immune Cell Infiltration
Trevor E. Angell et al.
THYROID (2014)
Whole-genome Sequencing of an Aggressive BRAF Wild-type Papillary Thyroid Cancer Identified EML4-ALK Translocation as a Therapeutic Target
Michael J. Demeure et al.
WORLD JOURNAL OF SURGERY (2014)
Current Thyroid Cancer Trends in the United States
Louise Davies et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2014)
Detection of BRAF V600E Mutation With Thyroid Tissue Using Pyrosequencing Comparison With PNA-Clamping and Real-Time PCR
Seong-Ho Kang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
Highly prevalent TERT promoter mutations in aggressive thyroid cancers
Xiaoli Liu et al.
ENDOCRINE-RELATED CANCER (2013)
Targeted Next-Generation Sequencing Panel (ThyroSeq) for Detection of Mutations in Thyroid Cancer
Marina N. Nikiforova et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Genomic Dissection of Hurthle Cell Carcinoma Reveals a Unique Class of Thyroid Malignancy
Ian Ganly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Frequent Somatic TERT Promoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease
Inigo Landa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers
Julio C. Ricarte-Filho et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
VIEWPOINT Increasing incidence of thyroid cancer: controversies explored
Yasuhiro Ito et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
BRAF V600E Inhibition in Anaplastic Thyroid Cancer
Michael H. Rosove et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
Alan L. Ho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Comprehensive MicroRNA Expression Profiling Identifies Novel Markers in Follicular Variant of Papillary Thyroid Carcinoma
Matthias Dettmer et al.
THYROID (2013)
Frequency of TERT promoter mutations in human cancers
Joao Vinagre et al.
NATURE COMMUNICATIONS (2013)
Molecular pathogenesis and mechanisms of thyroid cancer
Mingzhao Xing
NATURE REVIEWS CANCER (2013)
Immunohistochemical Detection of the BRAF V600E-mutated Protein in Papillary Thyroid Carcinoma
Oskar Koperek et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
The biology and the genetics of Hurthle cell tumors of the thyroid
Valdemar Maximo et al.
ENDOCRINE-RELATED CANCER (2012)
BRAFV600E Mutation Does Not Mean Distant Metastasis in Thyroid Papillary Carcinomas
Valentina Sancisi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
The BRAFV600E Mutation Is an Independent, Poor Prognostic Factor for the Outcome of Patients with Low-Risk Intrathyroid Papillary Thyroid Carcinoma: Single-Institution Results from a Large Cohort Study
Rossella Elisei et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Detection of BRAFV600E Mutations in Papillary Thyroid Carcinomas by Peptide Nucleic Acid Clamp Real-Time PCR: A Comparison with Direct Sequencing
Dongjun Jeong et al.
KOREAN JOURNAL OF PATHOLOGY (2012)
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
Erik K. Alexander et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Rearranged Anaplastic Lymphoma Kinase (ALK) Gene in Adult-Onset Papillary Thyroid Cancer Amongst Atomic Bomb Survivors
Kiyohiro Hamatani et al.
THYROID (2012)
Prognostic Factors and Treatment Outcomes for Anaplastic Thyroid Carcinoma: ATC Research Consortium of Japan Cohort Study of 677 Patients
Iwao Sugitani et al.
WORLD JOURNAL OF SURGERY (2012)
MicroRNA Signature Distinguishes the Degree of Aggressiveness of Papillary Thyroid Carcinoma
Linwah Yip et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
A Mutation Threshold Distinguishes the Antitumorigenic Effects of the Mitochondrial Gene MTND1, an Oncojanus Function
Giuseppe Gasparre et al.
CANCER RESEARCH (2011)
The Chernobyl Thyroid Cancer Experience: Pathology
V. A. LiVolsi et al.
CLINICAL ONCOLOGY (2011)
Dietary nitrate and nitrite and the risk of thyroid cancer in the NIH-AARP Diet and Health Study
Briseis A. Kilfoy et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
The Akt-Specific Inhibitor MK2206 Selectively Inhibits Thyroid Cancer Cells Harboring Mutations That Can Activate the PI3K/Akt Pathway
Ruixin Liu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Current State and Future Perspective of Molecular Diagnosis of Fine-Needle Aspiration Biopsy of Thyroid Nodules
Carolina Ferraz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome
Ingrid Slade et al.
JOURNAL OF MEDICAL GENETICS (2011)
Molecular genetics and diagnosis of thyroid cancer
Yuri E. Nikiforov et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling
J. A. Knauf et al.
ONCOGENE (2011)
Follicular Adenoma and Carcinoma of the Thyroid Gland
Christopher R. McHenry et al.
ONCOLOGIST (2011)
Gain of chromosome band 7q11 in papillary thyroid carcinomas of young patients is associated with exposure to low-dose irradiation
Julia Hess et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Interphase fluorescence in situ hybridization analysis detects a much higher rate of thyroid tumors with clonal cytogenetic deviations of the main cytogenetic subgroups than conventional cytogenetics
Norbert Drieschner et al.
CANCER GENETICS (2011)
Papillary Thyroid Carcinoma Variants
Ricardo V. Lloyd et al.
HEAD & NECK PATHOLOGY (2011)
The Spectrum of Papillary Thyroid Carcinoma Variants
Elham Khanafshar et al.
ADVANCES IN ANATOMIC PATHOLOGY (2010)
Detection of BRAF Mutations in Thyroid Nodules by Allele-Specific PCR Using a Dual Priming Oligonucleotide System
Hee Jin Lee et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Encapsulated Well-differentiated Follicular-patterned Thyroid Carcinomas Do Not Play a Significant Role in the Fatality Rates From Thyroid Carcinoma
Simonetta Piana et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Evaluation of the PAX8/PPARG Translocation in Follicular Thyroid Cancer with a 4-Color Reverse-Transcription PCR Assay and Automated High-Resolution Fragment Analysis
Alicia Algeciras-Schimnich et al.
CLINICAL CHEMISTRY (2010)
Hyalinizing trabecular tumour of the thyroid-differential expression of distinct miRNAs compared with papillary thyroid carcinoma
Sien-Yi Sheu et al.
HISTOPATHOLOGY (2010)
Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns
Michael Rivera et al.
MODERN PATHOLOGY (2010)
Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression
Sofia Asioli et al.
MODERN PATHOLOGY (2010)
The role of the PAX8/PPARγ fusion oncogene in the pathogenesis of follicular thyroid cancer
N. L. Eberhardt et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Prognostic utility of BRAF mutation in papillary thyroid cancer
Mingzhao Xing
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Molecular features of thyroid oncocytic tumors
Giuseppe Gasparre et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
miR-146b is Highly Expressed in Adult Papillary Thyroid Carcinomas with High Risk Features Including Extrathyroidal Invasion and the BRAFV600E Mutation
Chen-Kai Chou et al.
THYROID (2010)
Genetic Alterations in the Phosphatidylinositol-3 Kinase/Akt Pathway in Thyroid Cancer
Mingzhao Xing
THYROID (2010)
Genetic Predisposition to Familial Nonmedullary Thyroid Cancer: An Update of Molecular Findings and State-of-the-Art Studies
Elena Bonora et al.
JOURNAL OF ONCOLOGY (2010)
Genetic Alterations in the Phosphoinositide 3-Kinase/Akt Signaling Pathway Confer Sensitivity of Thyroid Cancer Cells to Therapeutic Targeting of Akt and Mammalian Target of Rapamycin
Dingxie Liu et al.
CANCER RESEARCH (2009)
Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for BRAF, PIK3CA, and AKT1
Julio C. Ricarte-Filho et al.
CANCER RESEARCH (2009)
BRAF Mutation in Papillary Thyroid Carcinoma in a Japanese Population: Its Lack of Correlation with High-Risk Clinicopathological Features and Disease-Free Survival of Patients
Yasuhiro Ito et al.
ENDOCRINE JOURNAL (2009)
RAS Mutations Are the Predominant Molecular Alteration in Poorly Differentiated Thyroid Carcinomas and Bear Prognostic Impact
Marco Volante et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Association of High Iodine Intake with the T1799A BRAF Mutation in Papillary Thyroid Cancer
Haixia Guan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Understanding the Relationship Between Age and Thyroid Cancer
Megan R. Haymart
ONCOLOGIST (2009)
The first 30 years of p53: growing ever more complex
Arnold J. Levine et al.
NATURE REVIEWS CANCER (2009)
Conventional and molecular cytogenetics of human non-medullary thyroid carcinoma: characterization of eight cell line models and review of the literature on clinical samples
Franclim Ricardo Ribeiro et al.
BMC CANCER (2008)
CREB3L2-PPARγ fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis
Weng-Onn Lui et al.
CANCER RESEARCH (2008)
Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma
Johannes A. Mayr et al.
CLINICAL CANCER RESEARCH (2008)
BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma
Angela M. Costa et al.
CLINICAL ENDOCRINOLOGY (2008)
Dysregulation of the phosphatidylinositol 3-kinase pathway in thyroid neoplasia
John E. Paes et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2008)
Phosphatidylinositol 3-Kinase/Akt and Ras/RafMitogen-Activated protein kinase pathway mutations in anaplastic thyroid cancer
Libero Santarpia et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
BRAFV600E mutation and outcome of patients with papillary thyroid carcinoma:: A 15-year median follow-up study
Rossella Elisei et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers
Zhi Liu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Morphologic characteristics of Chernobyl-related childhood papillary thyroid carcinomas are independent of radiation exposure but vary with iodine intake
E. Dillwyn Williams et al.
THYROID (2008)
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas
R. Visone et al.
ONCOGENE (2007)
Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma
Hwei-Ming Wang et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Poorly differentiated thyroid carcinoma: The Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach
Marco Volante et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism
C. Durante et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors
Giuseppe Gasparre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer
Peng Hou et al.
CLINICAL CANCER RESEARCH (2007)
High prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase/Akt pathway in thyroid tumors
Yangang Wang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin
N. Drieschner et al.
THYROID (2006)
Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas:: Effects of the detection methods and genetic heterogeneity
Zhaowen Zhu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III
Elena Bonora et al.
CANCER RESEARCH (2006)
RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: Follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma
Kerry J. Rhoden et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Follicular carcinoma presenting as autonomous functioning thyroid nodule and containing an activating mutation of the TSH receptor (T620I) and a mutation of the Ki-RAS (G12C) genes
Hugo Niepomniszcze et al.
THYROID (2006)
Pathogenetic mechanisms in thyroid follicular-cell neoplasia
T Kondo et al.
NATURE REVIEWS CANCER (2006)
Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas
AJ Adeniran et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
PAX8-PPAR gamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma
P Castro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
The role of microRNA genes in papillary thyroid carcinoma
HL He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer
MZ Xing et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Mutation of the PIK3CA gene in anaplastic thyroid cancer
G García-Rostán et al.
CANCER RESEARCH (2005)
Adenomas and follicular carcinomas of the thyroid display two major patterns of chromosomal changes
P Castro et al.
JOURNAL OF PATHOLOGY (2005)
Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness
V Trovisco et al.
VIRCHOWS ARCHIV (2005)
Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations
RM Quiros et al.
CANCER (2005)
Molecular pathogenesis of euthyroid and toxic multinodular goiter
K Krohn et al.
ENDOCRINE REVIEWS (2005)
Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid
V Maximo et al.
BRITISH JOURNAL OF CANCER (2005)
Anaplastic thyroid carcinoma - Treatment outcome and prognostic factors
E Kebebew et al.
CANCER (2005)
Molecular profile of hyalinizing trabecular tumours of the thyroid:: High prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations
G Salvatore et al.
EUROPEAN JOURNAL OF CANCER (2005)
PPAR gamma staining as a surrogate for PAX8/PPAR gamma fusion oncogene expression in follicular neoplasms: Clinicopathological correlation and histopathological diagnostic value
M Sahin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma
KJ Rhoden et al.
LABORATORY INVESTIGATION (2004)
Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker
VB Wreesmann et al.
CANCER RESEARCH (2004)
Identification of a gene rearranged by 2p21 aberrations in thyroid adenomas
V Rippe et al.
ONCOGENE (2003)
ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer
G Garcia-Rostan et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Aneuploidy in oncocytic lesions of the thyroid gland: Diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations
T Dettori et al.
GENES CHROMOSOMES & CANCER (2003)
Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma -: An unusually high prevalence of ras mutations
ZW Zhu et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
Thyroid gland clonality revisited: The embryonal patch size of the normal human thyroid gland is very large, suggesting X-chromosome inactivation tumor clonality studies of thyroid tumors have to be interpreted with caution
L Jovanovic et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Specific pattern of RAS oncogene mutations in follicular thyroid tumors
V Vasko et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
RAS point mutations and PAX8-PPARγ rearrangement in thyroid tumors:: Evidence for distinct molecular pathways in thyroid follicular carcinoma
MN Nikiforova et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas
MN Nikiforova et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Genome-wide appraisal of thyroid cancer progression
VB Wreesmann et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Chromosomal aberrations by comparative genomic hybridization in Hurthle cell thyroid carcinomas are associated with tumor recurrence
N Wada et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
PAX8-PPARγ rearrangement in thyroid tumors -: RT-PCR and immunohistochemical analyses
MN Nikiforova et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma - A search for the early precursors of papillary cancer
A Fusco et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology -: A study with emphasis on Hurthle cell tumors
V Máximo et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma
R Ivanova et al.
VIRCHOWS ARCHIV (2002)
RET/PTC rearrangement in thyroid tumors
YE Nikiforov
ENDOCRINE PATHOLOGY (2002)
RET oncogene activation in papillary thyroid carcinoma
G Tallini et al.
ADVANCES IN ANATOMIC PATHOLOGY (2001)
Gain of 1q and loss of 9q21.3-q32 are associated with a less favorable prognosis in papillary thyroid carcinoma
P Kjellman et al.
GENES CHROMOSOMES & CANCER (2001)
Analysis of hurthle cell neoplasms of the thyroid by interphase fluorescence in situ hybridization
LA Erickson et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
β-Catenin dysregulation in thyroid neoplasms -: Down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis
G Garcia-Rostan et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Delineation of a 150-kb breakpoint cluster in benign thyroid tumors with 19q13.4 aberrations
G Belge et al.
CYTOGENETICS AND CELL GENETICS (2001)
Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma
TJ Musholt et al.
SURGERY (2000)
PAX8-PPARγ1 fusion in oncogene human thyroid carcinoma
TG Kroll et al.
SCIENCE (2000)
Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors
O Gimm et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
N-ras mutation in poorly differentiated thyroid carcinomas: Correlation with bone metastases and inverse correlation to thyroglobulin expression
F Basolo et al.
THYROID (2000)
Share Paper
